RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

Learning how to adjust a Parkinson’s medicine pump

Researchers collect everyday treatment experience with foslevodopa and foscarbidopa infusions, including how delivery rates are adjusted for advanced Parkinson’s.

Learning by observing or collecting information · Study reference: NCT06937034

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (reported actual date)
2025-04-14
Main measurements finished (planned)
2025-12
Study finished (planned)
2025-12

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: The ORCHESTRA Study.
Listed by the registry as research derived from the study · 2026

Who can join?

Age 18 years and over · Does not accept healthy volunteers

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: all

Inclusion Criteria: \- Diagnosed with levodopa-responsive idiopathic Parkinson's Disease prescribed on LDp/CDp CSCI in routine clinical practice who have consented to be enrolled in the AbbVie Patient Support Program.
Full study name & original research details

Official study title

Observational Retrospective CoHort Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease

Short title used by the registry

Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease

Original description

Main objective of this study is to describe the evolution of infusion settings (base, high and low infusion rates) of foslevodopa/foscarbidopa subcutaneous infusion (LDp/CDp) at different timepoints in the treatment of advanced Parkinson's disease (aPD) as captured in ONE-CRM.

Conditions reported: Parkinson's Disease

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Observational
Interventions
Not reported
Phases
Not reported
Sponsor
AbbVie
Start date reported by registry
2025-04-14 (actual)

Registry updated: 2025-08-05 · Status last verified by the registry submitter: 2025-08

Registry records retrieved 2026-10-13 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Medizinische Universitaet Graz /ID# 278569

Graz, Styria, Austria

Not yet recruiting

Medisch Spectrum Twente /ID# 276695

Enschede, Overijssel, Netherlands

Recruiting

Universitatea De Medicină Și Farmacie Victor Babeș /ID# 276720

Timișoara, Timiș County, Romania

Recruiting

Karolinska University Hospital Solna /ID# 277116

Solna, Stockholm County, Sweden

Recruiting

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.